The 20 Best Embryonal Tumor with Multilayered Rosettes Doctors Near Me in Arlington, VA

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer.

Matthew Ladra, M.D., M.P.H., leads the dedicated pediatric team for the Johns Hopkins Proton Therapy Center and is the director of pediatric radiation oncology for the Johns Hopkins Kimmel Cancer Center, a clinical collaboration with Children’s National Hospital, where Dr. Ladra serves as faculty in the department of pediatric oncology. He is also an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins School of Medicine. Listen Dr. Ladra's Cancer Matters podcast episode to learn more about his work. Previously, Dr. Ladra served as the director of pediatric radiation at the Provision Center for Proton Therapy in Tennessee. He also completed a 2-year fellowship in pediatric proton therapy at the Massachusetts General Hospital’s Francis H. Burr Proton Center. Dr. Ladra is one of a handful of radiation oncologists whose research and clinical efforts focus exclusively on pediatric patients. He is frequently invited to speak on pediatric radiation oncology topics internationally and across the U.S. and has published extensively on the subject through original research book chapters and review articles. Dr. Ladra’s research efforts focus mainly on pediatric rhabdomyosarcoma treatment, early phase clinical trials involving radiation and non-chemotherapeutic agents, and reducing neurocognitive toxicity for pediatric brain tumor patients. LinkedIn https://www.linkedin.com/in/matthew-ladra-3094a316. Dr. Ladra is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Rhabdomyosarcoma, Muscle Invasive Bladder Cancer, Adult Soft Tissue Sarcoma, and Ependymoma.

Deepa Subramaniam is an Internal Medicine provider in Washington, Washington, D.c.. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.

Marie Kate Gurka, M.D., is a radiation oncologist in the Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Gurka has expertise in radiation treatment for breast cancer and gynecologic cancers. Dr. Gurka earned her medical degree from Virginia Commonwealth University and completed a residency in radiation oncology at Georgetown University Hospital. She previously served as an instructor in the Department of Radiation Oncology at University of Louisville and has conducted both clinical and basic science research. Her work has been recognized by the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO), and it has been cited in various lectures, research articles, and textbooks. Washingtonian Magazine and Bethesda Magazine have repeatedly named Dr. Gurka a Top Doctor. Selected Publications Oermann EK, Bhandari R, Chen V, Lebec G, Gurka M, Lei S, Chen L, Suy, S, Azumi N, Berkowitz F, Kalhorn C, McGrail K, Collins BT, Jean W, Collins SP. Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas. Frontiers in Radiation Oncology. 2013; 3: 213. Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic Body Radiation Therapy with Concurrent Full-Dose Gemcitabine for Locally Advanced Pancreatic Cancer: A Pilot Trial Demonstrating Safety. Radiation Oncology. 2013; 8: 44. Gurka MK, Kim C , Carroll J, Charabaty A, Haddad M, Jackson P, Collins SP, Marshall J, Pishvaian MK, Unger KR. Stereotactic Body Radiation Therapy (SBRT) combined with chemotherapy for unresected pancreatic adenocarcinoma. American Journal of Clinical Oncology. 2014; 152-157. Gurka MK, Horne ZD, Ju A, Chen L, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch JH, Collins SP. Hematuria Following Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer. Radiation Oncology. 2015; 10:44. Gurka MK, Pender D, Chuong P, Fouts B, Sebelov A, McNally M, Mezera M, Woo SY, McNally R. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. Journal of Controlled Release. 2016; 231:60-67. Dr. Gurka is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Gliomatosis Cerebri, and Marginal Zone Lymphoma (MZL).

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Roger Packer is a Pediatrics provider in Washington, Washington, D.c.. Dr. Packer is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Neurofibromatosis, and Gliomatosis Cerebri.

Brian Rood is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Rood is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant.

Karun Sharma is a Radiologist in Washington, Washington, D.c.. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Horseshoe Kidney, Mesenteric Venous Thrombosis, Cerebral Hypoxia, Liver Embolization, and Gastrostomy.

Catherine Bollard is a Pediatrics provider in Washington, Washington, D.c.. Dr. Bollard is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Niti Dham is a Pediatric Cardiologist in Washington, Washington, D.c.. Dr. Dham is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Hypochondroplasia, Rommen Mueller Sybert Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), and Pediatric Myocarditis.

Brownstein Chair, Brain Tumor Research Co-Director, Neuro-Oncology, Inova Schar CancerDr. Adam L. Cohen is a specialty care physician board certified in neuro-oncology, medical oncology and internal medicine. He received his MS from the University of Chicago and MD from Harvard. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Neuroepithelioma, Bone Marrow Aspiration, and Liver Embolization.

Dr. Mateo Ziu is board certified in neurological surgery. He joined Inova Medical Group with more than 12 years of clinical experience and serves as the medical director of Inova Brain and Spine Tumor Program and medical director of neuro-oncology at Inova Schar Cancer Institute. He has completed a fellowship and gained advance training in the surgical management of brain, spine and pituitary tumors. He has a keen interest in the delivery of multidisciplinary evidence-based care for patients with benign and malignant nervous system tumors. He collaborates with world-wide clinical investigators in multiple clinical trials for patients with these tumors. Before joining Inova Medical Group Neurosurgery, Dr. Ziu practiced in Austin, TX where he was the Medical Director of the Brain and Spine Tumor Program and Pituitary Care Center of Seton Brain and Spine Institute. He was an Assistant Professor at the Dell. Dr. Ziu is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Metastatic Brain Tumor, Glioblastoma, Astrocytoma, Awake Craniotomy, and Laminectomy.

John Hamilton is a Neurosurgery provider in Fairfax, Virginia. Dr. Hamilton is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Subdural Hematoma, Bone Graft, and Vertebroplasty.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Edina Komlodi is a Neurologist in Washington, Washington, D.c.. Dr. Komlodi is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Brain Tumor, Embryonal Tumor with Multilayered Rosettes, Glioma, and Glioblastoma.

Jeffrey Toretsky is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Toretsky is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.